Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Clinical trial NCT04420689 · COMPLETED

Trial details

NCT number: NCT04420689
Sponsor: Alume Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parotid Neoplasm Thyroid Neoplasms Head and Neck Neoplasms Surgery Nerve Injury Imaging

Start date: 2020-06-18
Primary completion: 2021-06-25
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.